Latest Financial Performance News

Bailador Technology Investments reports a 33% rise in net profit for HY26 and declares a fully-franked interim dividend, underpinned by robust portfolio company valuations and cash realisations.

Macquarie Group reports solid 3Q26 results with robust profit growth across divisions and a strong capital surplus, underpinned by strategic technology investments and regulatory compliance.

Reckon Limited has reported a robust 66.7% increase in net profit for the 2025 financial year, driven by strong revenue growth and the acquisition of Cashflow Manager. The company maintains its dividend policy amid expanding subscription revenues.

Bailador Technology Investments reported a 33% increase in net profit after tax for H1 FY26, driven by strong portfolio gains and a partial realisation of SiteMinder shares. The company declared a fully franked interim dividend of 3.9 cents per share, maintaining its steady dividend policy.

Region Group has reported a solid half-year financial performance ending December 2025, with increased revenue, net profit, and distributions, backed by an unqualified auditor review.

Dexus Convenience Retail REIT has reported solid half-year results for 2026, underpinned by resilient income growth and a $19.8 million uplift in portfolio valuation. The fund maintains a conservative capital structure while advancing key development projects.

Dexus Convenience Retail REIT (DXC) reports solid HY26 results with strong income growth and high occupancy, while advancing strategic development projects to enhance its metro and highway retail footprint.

Scentre Group has announced an ordinary dividend of AUD 0.08905 per security for the six months ending December 2025, with a Dividend Reinvestment Plan option available. The full year results will be released on 24 February 2026.

Dexus Convenience Retail REIT has reported a striking 143.8% increase in net profit for the half-year to December 2025, underpinned by strong portfolio occupancy and rising property valuations. The REIT reaffirmed its FY26 guidance, signalling confidence in its defensive income strategy and development pipeline.

Algorae Pharmaceuticals has secured a key Licence & Supply Agreement with Cadila Pharmaceuticals to commercialise two generic cardiovascular and metabolic medicines in Australia and New Zealand, broadening its therapeutic reach beyond oncology.

CAR Group Limited has reported a strong first half for FY26, posting 13% revenue growth and reaffirming its optimistic outlook for the full year, driven by strategic AI integration and global market expansion.

CAR Group has reported strong first-half results for FY26, with double-digit revenue and earnings growth across all key regions, underpinned by strategic AI investments and expanding market presence.